U.S. FTC clears Valeant deal for Medicis Pharmaceutical
Posted on November 16, 2012 at 09:03 AM EST
Nov 16 (Reuters) - The U.S. Federal Trade Commission has cleared Valeant Pharmaceuticals International Inc's $2.6 billion deal to buy U.S. dermatology rival Medicis Pharmaceutical Corp, without conditions, Valeant said on Friday.